Subcommittee on Procedures Review, Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH), 15761-15762 [2012-6475]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 52 / Friday, March 16, 2012 / Notices
Web site after the meeting, at https://
healthit.hhs.gov.
Procedure: Interested persons may present
data, information, or views, orally or in
writing, on issues pending before the
workgroups. Written submissions may be
made to the contact person on or before two
days prior to the workgroup’s meeting date.
Oral comments from the public will be
scheduled at the conclusion of each
workgroup meeting. Time allotted for each
presentation will be limited to three minutes.
If the number of speakers requesting to
comment is greater than can be reasonably
accommodated during the scheduled open
public session, ONC will take written
comments after the meeting until close of
business on that day.
Persons attending ONC’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
ONC welcomes the attendance of the
public at its advisory committee meetings.
Seating is limited at the location, and ONC
will make every effort to accommodate
persons with physical disabilities or special
needs. If you require special accommodations
due to a disability, please contact Mary Jo
Deering at least seven (7) days in advance of
the meeting.
ONC is committed to the orderly conduct
of its advisory committee meetings. Please
visit our Web site at https://healthit.hhs.gov
for procedures on public conduct during
advisory committee meetings.
Notice of this meeting is given under the
Federal Advisory Committee Act (Pub. L. 92–
463, 5 U.S.C., App. 2).
Dated: March 8, 2012.
Mary Jo Deering,
Office of Policy and Planning, Office of the
National Coordinator for Health Information
Technology.
[FR Doc. 2012–6437 Filed 3–15–12; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
mstockstill on DSK4VPTVN1PROD with NOTICES
Office of the Assistant Secretary for
Health, Statement of Organization,
Functions, and Delegation of Authority
Part A. Office of the Secretary,
Statement of Organization, Functions,
and Delegation of Authority for the U.S.
Department of Health and Human
Services is being amended at Chapter
AC, Office of the Assistant Secretary for
Health (OASH), as last amended at 60
FR 56605–06, dated November 9, 1995;
60 FR 8410, dated February 14, 1995;
and most recently at 75 FR 53304–05,
dated August 31, 2010, as follows:
1. Under Chapter AC, delete
Paragraph H, ‘‘Office of HIV/AIDS
Policy (ACJ)’’, in its entirety and replace
with the following:
VerDate Mar<15>2010
17:10 Mar 15, 2012
Jkt 226001
H. Office of HIV/AIDS and Infectious
Disease Policy (ACJ)
The Office of HIV/AIDS and
Infectious Disease Policy (OHAIDP) is
under the direction of the Deputy
Assistant Secretary for Health,
Infectious Diseases, who serves as the
Director of the Office of HIV/AIDS and
Infectious Disease Policy, and as the
principal advisor to the Assistant
Secretary for Health (ASH) and the
Secretary on health policy and program
issues related to HIV disease and
infectious diseases of public health
significance. These issues cut across
Health and Human Services (HHS)
components which provide research,
services, prevention, treatment, and
education and information
dissemination to susceptible
populations.
OHAIDP is responsible for
coordinating, integrating, and directing
the Department’s policies, programs,
and activities related to HIV/AIDS, viral
hepatitis, other infectious diseases of
public health significance, and blood
safety and availability. The Office: (1)
Facilitates and/or coordinates policy
planning processes related to infectious
diseases, including viral hepatitis and
HIV/AIDS, across HHS and monitors
progress toward achieving established
goals; (2) Advises on issues related to
blood and blood products; (3) Monitors
the implementation of the National HIV/
AIDS Strategy across HHS; (4) Identifies
critical HIV/AIDS policy issues,
including the inter-and intra-agency
coordination need, and advises on how
best to address/resolve these issues; (5)
Serves as HHS liaison with the Office of
the National AIDS Policy Coordinator,
Executive Office of the President; (6)
Assists in the preparation of responses
to inquiries regarding programs and
policies intended to promote effective
prevention and advancement of research
for HIV/AIDS, viral hepatitis, and other
infectious diseases of public health
significance; (7) Provides liaison with
other Federal organizations involved in
addressing HIV/AIDS, viral hepatitis
and/or other infectious diseases of
public health significance; (8) Provides
analytic and administrative support to
the Advisory Committee on Blood
Safety and Availability (ACBSA), the
Presidential Advisory Council on HIV/
AIDS (PACHA), cross-Departmental,
coordinating groups, and other
subsidiary or independent task forces,
work groups, or subgroups; (9) Provides
guidance on the cooperative
dissemination and exchange of
scientific, prevention, educational
information, and clinical guidelines
between public health interest groups,
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
15761
health professional, and private sector
organizations; (10) Guides, supports,
and promotes methods of dissemination
and exchange of information to and
among the public; (11) Reviews and
makes recommendations on OPDIVs
budget requests related to departmental
research, prevention, services, training,
information, and infrastructure
priorities as incorporated in planning
documents or budget proposals.
II. Delegations of Authority. Pending
further re-delegation, directives or
orders made by the Secretary, the
Assistant Secretary for Health, or the
Deputy Assistant Secretary for Health,
Infectious Diseases, all delegations and
re-delegations of authority made to
officials and employees of the affected
organizational component will continue
in them pending further re-delegations,
provided they are consistent with this
reorganization.
Dated: March 6, 2012.
E.J. Holland, Jr.,
Assistant Secretary for Administration.
[FR Doc. 2012–6466 Filed 3–15–12; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee on Procedures Review,
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 9 a.m.–5 p.m., April
11, 2012.
Place: Cincinnati Airport Marriott,
2395 Progress Drive, Hebron, Kentucky
41018, Telephone (859) 334–4611, Fax
(859) 334–4619.
Status: Open to the public, but
without a verbal public comment
period. Written comment should be
provided to the contact person below in
advance of the meeting. To access by
conference call dial the following
information 1 (866) 659–0537,
Participant Pass Code 9933701.
Background: The ABRWH was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
E:\FR\FM\16MRN1.SGM
16MRN1
mstockstill on DSK4VPTVN1PROD with NOTICES
15762
Federal Register / Vol. 77, No. 52 / Friday, March 16, 2012 / Notices
compensation program. Key functions of
the ABRWH include providing advice
on the development of probability of
causation guidelines that have been
promulgated by the Department of
Health and Human Services (HHS) as a
final rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule;
advice on the scientific validity and
quality of dose estimation and
reconstruction efforts being performed
for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special
Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the ABRWH to
HHS, which subsequently delegated this
authority to CDC. NIOSH implements
this responsibility for CDC. The charter
was issued on August 3, 2001, renewed
at appropriate intervals, and will expire
on August 3, 2013.
Purpose: The ABRWH is charged with
(a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b)
providing advice to the Secretary, HHS,
on the scientific validity and quality of
dose reconstruction efforts performed
for this program; and (c) upon request
by the Secretary, HHS, advising the
Secretary on whether there is a class of
employees at any Department of Energy
facility who were exposed to radiation
but for whom it is not feasible to
estimate their radiation dose, and on
whether there is a reasonable likelihood
that such radiation doses may have
endangered the health of members of
this class. The Subcommittee on
Procedures Review was established to
aid the ABRWH in carrying out its duty
to advise the Secretary, HHS, on dose
reconstructions. The Subcommittee on
Procedures Review is responsible for
overseeing, tracking, and participating
in the reviews of all procedures used in
the dose reconstruction process by the
NIOSH Division of Compensation
Analysis and Support (DCAS) and its
dose reconstruction contractor.
Matters to be Discussed: The agenda
for the Subcommittee meeting includes
discussion of the following Oak Ridge
Associated Universities (ORAU) and
Division of Compensation Analysis and
Support (DCAS) procedures: Office of
Compensation Analysis and Support
(OCAS) TIB–0010 ‘‘Best Estimate
External Dose Reconstruction for
Glovebox Workers’’); DCAS TIB–0013
(‘‘Selected Geometric Exposure Scenario
Considerations for External Dose
Reconstruction at Uranium Facilities’’),
OTIB–0052 (‘‘Parameters to Consider
When Processing Claims for
VerDate Mar<15>2010
17:10 Mar 15, 2012
Jkt 226001
Construction Trade Workers’’), OTIB–
0054 (‘‘Fission and Activation Product
Assignment for Internal Dose-Related
Gross Beta and Gross Gamma
Analyses’’), and PER 20 (‘‘Blockson TBD
Revision’’); Identification of
Overarching Dose Reconstruction
Issues; Discussion of Completed
Procedure Reviews for Summarization;
and a continuation of the commentresolution process for other dose
reconstruction procedures under review
by the Subcommittee.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted. Any written comments
received will be provided at the meeting
and should be submitted to the contact
person below well in advance of the
meeting.
Contact Person for More Information:
Theodore Katz, Executive Secretary,
NIOSH, CDC, 1600 Clifton Road NE.,
Mailstop E–20, Atlanta, Georgia 30333,
Telephone (513) 533–6800, Toll Free 1
(800) CDC–INFO, Email dcas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: March 9, 2012.
John Kastenbauer,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2012–6475 Filed 3–15–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0627]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; General
Administrative Procedures: Citizen
Petitions; Petition for Reconsideration
or Stay of Action; Advisory Opinions
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
SUMMARY:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by April 16,
2012.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0183. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT: Ila
S. Mizrachi, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
7726, Ila.Mizrachi@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
General Administrative Procedures:
Citizen Petitions; Petition for
Reconsideration or Stay of Action;
Advisory Opinions—(OMB Control
Number 0910–0183)—Extension
The Administrative Procedures Act (5
U.S.C. 553(e)), provides that every
Agency shall give an interested person
the right to petition for issuance,
amendment, or repeal of a rule. Section
10.30 (21 CFR 10.30) sets forth the
format and procedures by which an
interested person may submit to FDA, in
accordance with § 10.20 (21 CFR 10.20)
(submission of documents to Division of
Dockets Management), a citizen petition
requesting the Commissioner of FDA
(the Commissioner) to issue, amend, or
revoke a regulation or order, or to take
or refrain from taking any other form of
administrative action.
The Commissioner may grant or deny
such a petition, in whole or in part, and
may grant such other relief or take other
action as the petition warrants.
Respondents are individuals or
households, State or local governments,
not-for-profit institutions or groups.
Section 10.33 (21 CFR 10.33) issued
under section 701(a) of the Federal
Food, Drug, and Cosmetic Act (the
FD&C Act) (21 U.S.C. 371(a)), sets forth
the format and procedures by which an
interested person may request
reconsideration of part or all of a
decision of the Commissioner on a
petition submitted under 21 CFR 10.25
(initiation of administrative
E:\FR\FM\16MRN1.SGM
16MRN1
]]>Agencies
[Federal Register Volume 77, Number 52 (Friday, March 16, 2012)]
[Notices]
[Pages 15761-15762]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-6475]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee on Procedures Review, Advisory Board on Radiation
and Worker Health (ABRWH), National Institute for Occupational Safety
and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting for the aforementioned
subcommittee:
Time and Date: 9 a.m.-5 p.m., April 11, 2012.
Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron,
Kentucky 41018, Telephone (859) 334-4611, Fax (859) 334-4619.
Status: Open to the public, but without a verbal public comment
period. Written comment should be provided to the contact person below
in advance of the meeting. To access by conference call dial the
following information 1 (866) 659-0537, Participant Pass Code 9933701.
Background: The ABRWH was established under the Energy Employees
Occupational Illness Compensation Program Act of 2000 to advise the
President on a variety of policy and technical functions required to
implement and effectively manage the
[[Page 15762]]
compensation program. Key functions of the ABRWH include providing
advice on the development of probability of causation guidelines that
have been promulgated by the Department of Health and Human Services
(HHS) as a final rule; advice on methods of dose reconstruction which
have also been promulgated by HHS as a final rule; advice on the
scientific validity and quality of dose estimation and reconstruction
efforts being performed for purposes of the compensation program; and
advice on petitions to add classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the ABRWH to HHS, which subsequently
delegated this authority to CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August 3, 2001, renewed at
appropriate intervals, and will expire on August 3, 2013.
Purpose: The ABRWH is charged with (a) providing advice to the
Secretary, HHS, on the development of guidelines under Executive Order
13179; (b) providing advice to the Secretary, HHS, on the scientific
validity and quality of dose reconstruction efforts performed for this
program; and (c) upon request by the Secretary, HHS, advising the
Secretary on whether there is a class of employees at any Department of
Energy facility who were exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and on whether there is a
reasonable likelihood that such radiation doses may have endangered the
health of members of this class. The Subcommittee on Procedures Review
was established to aid the ABRWH in carrying out its duty to advise the
Secretary, HHS, on dose reconstructions. The Subcommittee on Procedures
Review is responsible for overseeing, tracking, and participating in
the reviews of all procedures used in the dose reconstruction process
by the NIOSH Division of Compensation Analysis and Support (DCAS) and
its dose reconstruction contractor.
Matters to be Discussed: The agenda for the Subcommittee meeting
includes discussion of the following Oak Ridge Associated Universities
(ORAU) and Division of Compensation Analysis and Support (DCAS)
procedures: Office of Compensation Analysis and Support (OCAS) TIB-0010
``Best Estimate External Dose Reconstruction for Glovebox Workers'');
DCAS TIB-0013 (``Selected Geometric Exposure Scenario Considerations
for External Dose Reconstruction at Uranium Facilities''), OTIB-0052
(``Parameters to Consider When Processing Claims for Construction Trade
Workers''), OTIB-0054 (``Fission and Activation Product Assignment for
Internal Dose-Related Gross Beta and Gross Gamma Analyses''), and PER
20 (``Blockson TBD Revision''); Identification of Overarching Dose
Reconstruction Issues; Discussion of Completed Procedure Reviews for
Summarization; and a continuation of the comment-resolution process for
other dose reconstruction procedures under review by the Subcommittee.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted. Any written comments received will be provided at the
meeting and should be submitted to the contact person below well in
advance of the meeting.
Contact Person for More Information: Theodore Katz, Executive
Secretary, NIOSH, CDC, 1600 Clifton Road NE., Mailstop E-20, Atlanta,
Georgia 30333, Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO,
Email dcas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: March 9, 2012.
John Kastenbauer,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2012-6475 Filed 3-15-12; 8:45 am]
BILLING CODE 4163-18-P
